Kendall Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Kendall Capital Management's AMRX Position: Q3 2026 in Review
Kendall Capital Management held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 35,015 shares worth $705K. The position accounts for 0.12% of the portfolio, ranked #146.
Kendall Capital Management first reported a position in AMRX in Q2 2025 and has held it in 6 quarters since. 273 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Kendall Capital Management held 35,015 shares of Amneal Pharmaceuticals worth $705K as of Q3 2026.
- Kendall Capital Management left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
- Amneal Pharmaceuticals made up 0.12% of Kendall Capital Management's portfolio in Q3 2026, its #146 holding.
- Kendall Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- 273 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Kendall Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.